Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (dumas): study protocol for a multicenter randomized controlled phase ii trial

HIGHLIGHTS

• who: Nadinda A. M. van der Ende from the the National Institutes of Health Stroke Scale (NIHSS) at , h and, days, score on the modified Rankin scale (mRS) Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands have published the paper: Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial, in the Journal: (JOURNAL) of November/26,/2018
• what: The aim of this study is to assess the safety and efficacy of thrombolytic treatment . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.